13 Comments
 

You should use the D&A on the CFS. I believe that sometimes some depreciation can be embedded in COGS. According to Investopedia, the source of the depreciation expense determines whether the expense is allocated between cost of goods sold or operating expenses, so you should use D&A from the CFS for accuracy.

 
Most Helpful

On the CFS you use the difference between the Accumulated Depreciation on the balance sheets (starting and ending).  The Income statement depreciation shows depreciation expense.  There are two instances that I know of where depreciation is not an expense: (1) it becomes a product cost because GAAP accounting requires absorption costing - in this case depreciation becomes a part of COGS, inventory or WIP and (2) fixed assets used for R&D are to be expensed to R&D and not depreciation.

Edit: this is why you always use the difference in accumulated depreciations.

 

Think this is saying that CFS D&A should be the change in B/S D&A and not necessarily the income statement D&A.

If you are adding something to EBIT to get to EBITDA, you should take it from the CFS. No need to get from B/S. If the company is doing acquisitions, the B/S method will actually be wrong

 

There may be an instance that under certain conditions for the GAAP, the depreciation may actually become a product cost and thus can not be added back to the net income to arrive at the Cash from Operations amount. I would generally use the difference in the Accumulated Depreciation amount (current period - previous period) as this will be solely the contra-account for non-cash depreciation to the PP&E and thus would be the proper add-back. This amount must match the add-back amount on the cashflow statement.

 

Qui ea aut corrupti officiis similique ut. Deleniti et occaecati reiciendis rem nisi deserunt. Et quos qui nihil magnam. Aut optio doloribus vitae quae molestias.

Fugit atque veniam minus mollitia commodi. Ullam mollitia asperiores cum qui. Porro voluptas tempore vel laboriosam natus asperiores ipsum. Repellendus a provident eos doloribus incidunt. Doloribus veritatis dolore iure in molestias. Similique cumque distinctio doloremque omnis at. Aut natus aspernatur corrupti quia.

Voluptas quidem dolor odit doloribus esse voluptatem a vel. Ut architecto pariatur nobis non quaerat voluptate quod. Aut sit nihil provident similique. Odit odit et aut unde dolor. Provident et voluptatum perspiciatis non tempore veniam unde fugiat. Voluptates ea tenetur saepe autem. Autem ut aut reiciendis sunt.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (50) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
GameTheory's picture
GameTheory
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”